These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 32001534)

  • 1. Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management.
    Pignatelli P; Ettorre E; Menichelli D; Pani A; Violi F; Pastori D
    Haematologica; 2020 Mar; 105(3):562-572. PubMed ID: 32001534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome.
    Devreese KMJ
    Int J Lab Hematol; 2024 May; 46 Suppl 1():34-42. PubMed ID: 38584293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome.
    Truglia S; Mancuso S; Capozzi A; Recalchi S; Riitano G; Longo A; De Carolis S; Spinelli FR; Alessandri C; Ceccarelli F; De Carolis C; Misasi R; Sorice M; Conti F
    Rheumatology (Oxford); 2022 Feb; 61(2):826-833. PubMed ID: 33970223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid Syndrome.
    Khogeer H; Altahan S; Alrehaily A; Sheikh A; Awartani K; Al-Kaff M; Saleh S; Alzahrani H; Alfattani A; Owaidah T
    Ann Clin Lab Sci; 2021 Jul; 51(4):552-556. PubMed ID: 34452895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
    Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
    J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study.
    Abisror N; Nguyen Y; Marozio L; Esteve Valverde E; Udry S; Pleguezuelo DE; Billoir P; Mayer-Pickel K; Urbanski G; Zigon P; De Moreuil C; Hoxha A; Bezanahary H; Carbillon L; Kayem G; Bornes M; Yelnik C; Johanet C; Nicaise-Roland P; Lambert M; Salle V; Latino OJ; Hachulla E; Benedetto C; Bourrienne MC; Benhamou Y; Alijotas-Reig J; Fain O; Mekinian A;
    RMD Open; 2020 Aug; 6(2):0. PubMed ID: 32848089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid Phase Assays for Antiphospholipid Antibodies.
    Devreese KMJ
    Semin Thromb Hemost; 2022 Sep; 48(6):661-671. PubMed ID: 35675831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis.
    Capozzi A; Riitano G; Mancuso S; Recalchi S; Manganelli V; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Truglia S; Sorice M
    Clin Exp Immunol; 2021 Sep; 205(3):326-332. PubMed ID: 34107056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome.
    Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A
    Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seronegative antiphospholipid syndrome: Myth or reality?].
    Salle V
    Rev Med Interne; 2020 Apr; 41(4):265-274. PubMed ID: 32115196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.